Sign up
Quantellect · Congress · Trade Detail
NYSE: ABBVAbbVie Inc
RepublicanHouse

Gary J. Palmer sold AbbVie Inc (NYSE: ABBV)

Gary J. Palmer (R-AL), a U.S. Representative, has disclosed 4 trades in AbbVie Inc (ABBV) since 2017, 3 purchases and 1 sale, worth an estimated $32K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Gary J. Palmer sold $1,001 - $15,000 of AbbVie Inc (NYSE: ABBV) on September 18, 2018. Since that trade, ABBV is up +295.77% against the S&P 500 up +182.49%, an outperformance of +113.28%.

Across these filings, Gary J. Palmer has been a net buyer of ABBV (a buy-to-sell ratio of 3.00). Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

ABBV trades
4
Disclosed Vol
$32K
Buys
3
75%
Sells
1
25%
Buy / Sell
3.00
ratio
First → Last
2017–2018

Gary J. Palmer's ABBV trades vs the price

ABBV is up +295.77% since Gary J. Palmer sold on September 18, 2018, versus +182.49% for the S&P 500.

Performance since this trade

Price change since trade
+295.77%
S&P 500 change since trade
+182.49%
Outperformance vs S&P 500
+113.28%

All Gary J. Palmer ABBV trades

TradedTypeSizeReturnEst. profit
September 18, 2018SELL$66.53+295.77%
August 6, 2018BUY$69.72+277.63%+$14K
July 12, 2018BUY$68.68+283.36%+$14K
November 6, 2017BUY$64.96+305.32%+$15K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Gary J. Palmer & ABBV trading FAQ

Is it legal for Gary J. Palmer to trade AbbVie Inc (ABBV) stock?

Yes. Members of Congress are allowed to trade individual stocks, including AbbVie Inc (ABBV), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Gary J. Palmer sell ABBV?

Gary J. Palmer disclosed a sale of $1,001 - $15,000 of AbbVie Inc (ABBV) on September 18, 2018, according to public STOCK Act filings.

How has ABBV performed since Gary J. Palmer's trade?

Since Gary J. Palmer sold ABBV on September 18, 2018, the stock is up +295.77%, versus +182.49% for the S&P 500 over the same period, an outperformance of +113.28%.

How many times has Gary J. Palmer traded ABBV?

Gary J. Palmer has disclosed 4 ABBV trades since 2017 (3 purchases and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional ABBV trades?

Quantellect tracks every disclosed congressional trade in AbbVie Inc (ABBV) on the AbbVie Inc congressional trading page, which aggregates filings across all members of Congress.

Gary J. Palmer's ABBV tradesAll congressional filings for AbbVie IncGary J. Palmer's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.